What does SHORT TITLE. of Cardiovascular Disease Early Detection and Prevention Act of 2026 do?

This bill is formally titled the Cardiovascular Disease Early Detection and Prevention Act of 2026.

What does REQUIRING COVERAGE OF CERTAIN CARDIOVASCULAR TESTS WITHOUT COST of Cardiovascular Disease Early Detection and Prevention Act of 2026 do?

This section amends the Public Health Service Act to include testing for lipoprotein(a) and apolipoprotein B levels for individuals with specific cardiovascular risk factors. The Social Security Act is amended to require Medicare to cover these tests without cost-sharing for eligible individuals. Similarly, the Social Security Act is amended to require Medicaid to cover these tests without cost-sharing for eligible individuals. States providing benchmark or benchmark-equivalent coverage under Medicaid are required to include testing for lipoprotein(a) and apolipoprotein B levels for individuals with specified risk factors. The amendments related to the Public Health Service Act apply to plan years beginning 180 days after the Act's enactment. The amendments related to Medicare and Medicaid apply to items and services furnished on or after that same date.

Back to bills

Cardiovascular Disease Early Detection and Prevention Act of 2026

Q: What does Preamble of Cardiovascular Disease Early Detection and Prevention Act of 2026 do?

This bill proposes amendments to the Public Health Service Act and the Social Security Act. The proposed changes aim to require coverage of certain cardiovascular tests. Coverage would be mandated under group health plans, group and individual health insurance, and the Medicare and Medicaid programs. The bill seeks to eliminate cost-sharing for these cardiovascular tests.

Q: What does FINDINGS. of Cardiovascular Disease Early Detection and Prevention Act of 2026 do?

This section outlines findings related to cardiovascular disease. Cardiovascular disease is identified as the leading cause of death in the United States. Current cholesterol panels may not detect elevated Lipoprotein(a) (Lp(a)) and Apolipoprotein B (ApoB) levels. Approximately 1 in 5 Americans have elevated Lp(a) levels. Elevated Apolipoprotein B (ApoB) levels are stated to predict cardiovascular risk better than LDL cholesterol alone. Nearly 50 percent of heart attack survivors die within five years without effective risk management.

Last updated: 4/14/2026 · Introduced: 4/14/2026

Author: Sheila Cherfilus-McCormick (D-FL)

TL;DR (AI)

This bill mandates that group health plans, individual health insurance, Medicare, and Medicaid cover testing for lipoprotein(a) and apolipoprotein B levels for individuals with specific cardiovascular risk factors.
The bill eliminates cost-sharing requirements for these cardiovascular tests under Medicare and Medicaid.
States offering benchmark Medicaid coverage must include these tests for individuals with specified risk factors.

119th Congressin committeeOfficial page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 2 more.

4 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account